British Medical Bulletin 69:143-153 (2004)
British Medical Bulletin, Vol. 69 © The British Council 2004; all rights reserved
MMR: risk, choice, chance
Barton House Health Centre, London, UK
Correspondence to: Michael Fitzpatrick, General Practitioner, Barton House Health Centre, 233 Albion Road, London N16 9JT, UK. E-mail: fitz{at}easynet.co.uk
The unfolding of the measles, mumps and rubella (MMR) controversy reveals some of the key features of the cultural climate affecting matters of health and illness in contemporary society. A high level of anxiety around issues of health is reflected in a heightened sense of individual vulnerability to environmental dangers (such as atmospheric pollution, electromagnetic fields, bioterrorism) and in a general aversion to risk, particularly in relation to children. This mood has proved responsive to views sceptical, if not hostile, towards science and medicine and associated professionals, particularly in the sphere of immunization. The result is that uptake of MMR vaccination in the UK has fallen, from a peak of 92% in the mid-1990s to a national level of 82% in 2003 (at the age of two); in London uptake is now less than 75%—much less in some areas—causing a significant risk of outbreaks of measles. In the USA too, the proportion of parents opting out of regulations requiring immunization as a condition of school entry has increased significantly in some areas, though these controversies appear to have had little impact so far in continental Europe.
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  Y. D'Souza, E. Fombonne, and B. J. Ward No Evidence of Persisting Measles Virus in Peripheral Blood Mononuclear Cells From Children With Autism Spectrum Disorder Pediatrics, October 1, 2006; 118(4): 1664 - 1675. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Young, G. Carr, R. Hunt, W. McCracken, A. Skipp, and H. Tattersall Informed Choice and Deaf Children: Underpinning Concepts and Enduring Challenges J. Deaf Stud. Deaf Educ., July 1, 2006; 11(3): 322 - 336. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Gellatly, C. McVittie, and N. Tiliopoulos Predicting parents' decisions on MMR immunisation: a mixed method investigation Fam. Pract., December 1, 2005; 22(6): 658 - 662. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. M. Posfay-Barbe, U. Heininger, C. Aebi, D. Desgrandchamps, B. Vaudaux, and C.-A. Siegrist How Do Physicians Immunize Their Own Children? Differences Among Pediatricians and Nonpediatricians Pediatrics, November 1, 2005; 116(5): e623 - e633. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Colgrove and R. Bayer Could It Happen Here? Vaccine Risk Controversies And The Specter Of Derailment Health Aff., May 1, 2005; 24(3): 729 - 739. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. Bellaby Has the UK government lost the battle over MMR? BMJ, March 12, 2005; 330(7491): 552 - 553. [Full Text] [PDF]
|
|
|
|
 |
|
 W. M McMahon Review: vaccines containing thimerosal are not associated with autistic spectrum disorders in children Evid. Based Ment. Health, February 1, 2005; 8(1): 23 - 23. [Full Text] [PDF]
|
|